Variables | Frequency (%) |
---|---|
Gender | |
Female | 449 (50.1) |
Male | 448 (49.9) |
Age at switch | |
15–24 | 92 (10.3) |
25–34 | 440 (49.1) |
35–44 | 271 (30.2) |
≥ 45 | 94 (10.5) |
BMI | |
< 18.5 | 501 (55.9) |
18.5–24.99 | 324 (36.1) |
≥ 25 | 72 (8.0) |
Educational status | |
No formal education | 317 (35.3) |
Formal education | 580 (64.7) |
Occupation | |
Unemployed | 357 (39.8) |
Employed | 283 (31.5) |
Others | 257 (28.7) |
WHO clinical stage | |
I | 433 (48.3) |
II | 94 (10.5) |
III | 300 (33.4) |
IV | 70 (7.8) |
CPT prophylaxis | |
No | 113 (12.6) |
Yes | 784 (87.4) |
Reason for switch | |
Clinical failure | 302 (33.7) |
Immunological failure | 415 (46.3) |
Virological failure | 140 (15.6) |
Drug toxicity | 40 (4.5) |
Functional status | |
Working | 773 (86.2) |
Ambulatory | 109 (12.2) |
Bedridden | 15 (1.7) |
INH given | |
No | 694 (77.4) |
Yes | 203 (22.6) |
TB treatment | |
No | 749 (83.5) |
Yes | 148 (16.5) |
CD4 cell count | |
≥ 100 cells/mm3 | 340 (37.9) |
< 100 cells/mm3 | 557 (62.1) |